(Q33335297)

English

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

author name string

H M Prince

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D Rischin

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

G C Toner

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J F Seymour

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D Blakey

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Gates

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Eerhard

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Chapple

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Quinn

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Brettell

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Juneja

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Wolf

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E H Januszewicz

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

G Richardson

14

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Scarlett

15

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Briggs

16

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

955-961

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702650

0 references

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

21 January 2018

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

21 January 2018

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

21 January 2018

Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

21 January 2018

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

21 January 2018

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy dose escalation: case unproven

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel effectively mobilizes peripheral blood CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood CD34+ cell count reliably predicts autograft yield

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and interstitial pulmonary injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Interstitial pneumonitis as a late complication of high dose therapy with cyclophosphamide/thiotepa and peripheral blood progenitor cell rescue for carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702650

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702650

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33335297&oldid=1577711218"